Loading...
XLON
SVCT
Market cap2mUSD
Apr 21, Last price  
44.00GBP
Name

Seneca Growth Capital VCT PLC

Chart & Performance

D1W1MN
XLON:SVCT chart
P/E
—
P/S
—
EPS
—
Div Yield, %
3.41%
Shrs. gr., 5y
26.77%
Rev. gr., 5y
%
Revenues
-96k
L-97.16%
0000005,224,00011,00012,000-1,051,000-599,000-340,000179,000-592,0001,449,0002,267,000290,000-2,398,000-3,385,000-96,000
Net income
-2m
L-45.75%
-167,000-164,000-123,000-17,000-134,000-86,000-156,000-164,000-151,000-1,205,000-582,000-367,00066,000-715,0001,297,0002,096,000-2,749,000-2,671,000-3,742,000-2,030,000
CFO
-219k
L-14.79%
-390,000-122,000-173,00021,000-418,000228,000-157,000-205,000-78,000-152,000-132,000-109,000-106,000-138,000-194,000-288,000-481,000-459,000-257,000-219,000
Dividend
May 02, 20241.5 GBP/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

Seneca Growth Capital VCT plc functions as a specialized venture capital trust, channeling its efforts into providing growth capital. It strategically allocates capital to emerging biotechnology firms, alongside a pronounced preference for both unlisted and publicly traded MedTech enterprises. Its geographic investment scope encompasses the United Kingdom, specific French locales such as Île-de-France and Burgundy, and the wider landscape of developed European markets. Key financial criteria for its portfolio companies include annual revenues surpassing £10 million ($11.90 million), a gross profit margin exceeding 50%, and an operating profit margin above 10%.
URL
https://senecavct.co.uk/
IPO date
Apr 19, 2002
Employees
0
Domiciled in
GB
Incorporated in
GB

Valuation

Title
GBP in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT